View in EDS HTML Full Text PDF Full Text

Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers.

Saved in:
Bibliographic Details
Title: Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers.
Authors: King, Gentry G.1,2 (AUTHOR), Baker, Kelsey K.2 (AUTHOR), Coveler, Andrew L.1,2,3 (AUTHOR), Harris, William P.1,2,4 (AUTHOR), Cohen, Stacey A.1,2 (AUTHOR), Shankaran, Veena1,2 (AUTHOR), Zhen, David B.1,2 (AUTHOR), Safyan, Rachael A.1,2 (AUTHOR), Lee, Hannah H.1 (AUTHOR), Alidina, Annie1 (AUTHOR), Hensel, Jeniece1 (AUTHOR), Hibbert, Reina1 (AUTHOR), Durm, Greg A.3 (AUTHOR), LaFary, Yvonne C.3 (AUTHOR), Younger, Anne3 (AUTHOR), Kugel, Sita2 (AUTHOR), Collisson, Eric2 (AUTHOR), Konnick, Eric Q.1 (AUTHOR), Redman, Mary W.2 (AUTHOR), Schneider, Bryan P.3 (AUTHOR)
Source: Cancers. Jun2025, Vol. 17 Issue 11, p1830. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers17111830